Welcome to our dedicated page for INTUITIVE SURGICAL SEC filings (Ticker: ISRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Intuitive Surgical filings document operating results, governance matters, capital structure, and material events for a Nasdaq-listed medical technology company focused on robotic-assisted surgery. Its Form 8-K reports furnish quarterly and preliminary financial results, procedure information, and exhibits tied to da Vinci and Ion business performance.
Regulatory filings also cover shareholder voting matters, proxy governance, executive compensation, director elections, and officer-role changes. Other material-event disclosures record completed corporate actions, including the acquisition of da Vinci and Ion distribution operations in Europe, alongside formal disclosures about common stock and financial reporting matters.
Intuitive Surgical, Inc. increased the authorized amount under its common stock repurchase program to an aggregate $5.0 billion, to be funded with cash, cash equivalents, and investments. Repurchases may occur over time through open-market and other transactions and may be suspended or discontinued at any time.
At its April 30, 2026 annual meeting, stockholders elected ten directors, approved on an advisory basis the compensation of named executive officers, ratified PricewaterhouseCoopers LLP as auditor for the year ending December 31, 2026, and approved an amendment and restatement of the 2010 Incentive Award Plan.
The amended plan increases shares reserved for awards from 120,350,000 to 125,350,000, extends the plan term to January 29, 2036, and further specifies how awards are treated in a change in control.
GUTHART GARY S reported acquisition or exercise transactions in this Form 4 filing.
Intuitive Surgical Inc. director Gary S. Guthart received a grant of 554 restricted stock units tied to the company’s common stock. These RSUs were awarded at no cash cost per unit and represent a stock-based compensation award rather than an open-market purchase.
According to the terms, 100% of the RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service. After this grant, the reported holding for this RSU award is 554 units.
INTUITIVE SURGICAL INC director Monica P. Reed reported routine equity compensation activity. On April 30, 2026, she exercised 531 shares of restricted stock units into the same number of common shares, bringing her direct common stock holdings to 2,876 shares.
On the same date, she received a new grant of 554 restricted stock units. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
INTUITIVE SURGICAL INC director Jami K. Nachtsheim reported routine equity compensation activity, with only share acquisitions and no sales. On April 30, 2026, she exercised 531 Restricted Stock Units into Common Stock, bringing her direct Common Stock holdings to 6,902 shares.
On the same date she also received a new grant of 554 Restricted Stock Units tied to Common Stock. According to the filing, 100% of these RSUs will vest on the earlier of one year from grant or the next Annual Meeting of Stockholders, as long as she continues in service.
INTUITIVE SURGICAL INC director Leonard Keith R reported equity compensation activity involving Restricted Stock Units (RSUs) and common stock. He exercised 531 RSUs into 531 shares of common stock on April 30, 2026, and did not report any same-day sales.
Following the exercise, he held 901 shares of common stock directly. On the same date, he also received a grant of 554 RSUs tied to common stock. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service.
INTUITIVE SURGICAL INC director Amy L. Ladd reported compensation-related equity activity involving company stock. On April 30, 2026, she exercised 531 Restricted Stock Units, which converted into 531 shares of Common Stock, leaving her with 651 Common shares held directly after the transaction.
On the same date, she also received a new grant of 554 Restricted Stock Units, each representing a right to receive one share of Common Stock. According to the filing, 100% of these RSUs vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
Intuitive Surgical director Sreelakshmi Kolli reported equity compensation activity involving Restricted Stock Units (RSUs) and common stock. She exercised 531 RSUs into 531 shares of common stock and, after this transaction, directly held 1,510 shares of common stock.
She was also granted 554 new RSUs linked to common stock, which represent a new award of derivative securities. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
Intuitive Surgical director Amal M. Johnson exercised 531 Restricted Stock Units into 531 shares of Common Stock. The RSUs vested based on service, with 100% vesting on the earlier of one year from grant or the next Annual Meeting of Stockholders. After this conversion, Johnson directly holds 13,545 shares of Common Stock, and the reported RSU award has been fully converted with no remaining balance shown.
INTUITIVE SURGICAL INC director Lewis Chew reported routine equity compensation changes. On April 30, 2026, he exercised 531 shares of restricted stock units into an equal number of common shares, bringing his direct common stock holdings to 1,314 shares after the transaction.
On the same date, he also received a new grant of 554 restricted stock units, each representing one share of common stock. According to the terms, 100% of these RSUs will vest on the earlier of one year from grant or the next Annual Meeting of Stockholders, assuming he continues in service.
INTUITIVE SURGICAL INC director Joseph C. Beery reported routine equity compensation activity. On April 30, 2026, he exercised 531 shares of Restricted Stock Units into Common Stock, bringing his direct Common Stock holdings to 3,641 shares after the transactions.
On the same date, he received a new grant of 554 Restricted Stock Units. According to the footnote, 100% of these RSUs will vest on the earlier of one year from the grant date or the next Annual Meeting of Stockholders, subject to his continued service. The filing shows only acquisitions and no open‑market buying or selling.